Total Payments
$765.33
2024 Payments
$306.36
Companies
16
Transactions
31
Medicare Patients
2,202
Medicare Billing
$250,856

Payment Breakdown by Category

Food & Beverage$721.37 (94.3%)
Education$43.96 (5.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $721.37 29 94.3%
Education $43.96 2 5.7%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $231.28 9 $0 (2024)
PFIZER INC. $125.99 3 $0 (2024)
Celgene Corporation $69.12 4 $0 (2023)
Takeda Pharmaceuticals U.S.A., Inc. $51.12 3 $0 (2023)
INTUITIVE SURGICAL, INC. $48.29 1 $0 (2024)
Madrigal Pharmaceuticals $48.22 1 $0 (2024)
Novo Nordisk Inc $32.27 1 $0 (2021)
IRONWOOD PHARMACEUTICALS, INC $23.95 1 $0 (2024)
Regeneron Healthcare Solutions, Inc. $22.37 1 $0 (2024)
Medtronic, Inc. $21.00 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $306.36 12 PFIZER INC. ($48.56)
2023 $95.92 6 Celgene Corporation ($34.20)
2022 $168.16 5 ABBVIE INC. ($149.75)
2021 $48.78 2 Novo Nordisk Inc ($32.27)
2020 $11.69 1 Janssen Pharmaceuticals, Inc ($11.69)
2019 $122.18 4 PFIZER INC. ($77.43)
2017 $12.24 1 Merck Sharp & Dohme Corporation ($12.24)

All Payment Transactions

31 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/01/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.03 General
Category: IMMUNOLOGY
10/30/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $19.68 General
Category: Immunology
10/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $20.65 General
Category: IMMUNOLOGY
10/12/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $48.22 General
Category: LIVER DISEASE
10/08/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $22.37 General
Category: INFLAMMATION AND IMMUNOLOGY
10/02/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $18.17 General
Category: Immunology
09/30/2024 PFIZER INC. VELSIPITY (Drug) Food and Beverage In-kind items and services $27.34 General
Category: INFLAMMATION;PAIN
09/30/2024 PFIZER INC. XELJANZ (Drug) Food and Beverage In-kind items and services $21.22 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
05/22/2024 AIMMUNE THERAPEUTICS, INC. VOWST (Biological) Food and Beverage In-kind items and services $19.44 General
Category: GI
04/09/2024 INTUITIVE SURGICAL, INC. Da Vinci Surgical System (Device) Food and Beverage In-kind items and services $48.29 General
Category: SURGERY
04/01/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $23.95 General
Category: GI
01/03/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $21.00 General
Category: Sacral Nerve Stimulation
11/01/2023 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.67 General
Category: INTERNAL MEDICINE
06/12/2023 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $12.88 General
Category: IMMUNOLOGY
05/30/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.80 General
Category: Neuroscience
05/04/2023 AbbVie Inc. RINVOQ (Biological) Food and Beverage In-kind items and services $15.67 General
Category: IMMUNOLOGY
04/28/2023 Echosens North America, Inc. FibroScan (Device) Food and Beverage Cash or cash equivalent $10.50 General
Category: Elastography
03/15/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.40 General
Category: Neuroscience
10/11/2022 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.41 General
Category: Neuroscience
10/05/2022 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $23.06 General
Category: GASTROENTEROLOGY
10/04/2022 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $1.13 General
Category: GASTROENTEROLOGY
06/28/2022 ABBVIE INC. SKYRIZI (Biological), HUMIRA Food and Beverage In-kind items and services $15.13 General
Category: IMMUNOLOGY
04/05/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $110.43 General
Category: IMMUNOLOGY
08/27/2021 Novo Nordisk Inc Education In-kind items and services $32.27 General
07/30/2021 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.51 General
Category: Neuroscience

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 565 591 $305,230 $66,921
2022 12 550 578 $289,245 $63,932
2021 13 578 604 $299,185 $68,075
2020 13 509 560 $222,365 $51,929
Total Patients
2,202
Total Services
2,333
Medicare Billing
$250,856
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 103 103 $105,575 $20,722 19.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 74 74 $61,050 $9,029 14.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 42 43 $31,820 $7,308 23.0%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 83 87 $51,765 $6,590 12.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 77 95 $10,450 $6,171 59.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 39 39 $9,750 $4,648 47.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 33 34 $5,440 $3,028 55.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 16 16 $4,960 $2,168 43.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 11 11 $3,410 $1,701 49.9%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 40 41 $2,870 $1,471 51.2%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 11 $8,140 $1,397 17.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 13 13 $2,080 $1,132 54.4%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 12 12 $6,600 $815.99 12.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 12 $1,320 $741.36 56.2%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 114 114 $117,875 $22,350 19.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 60 60 $49,500 $6,239 12.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 75 78 $46,410 $6,195 13.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 78 92 $10,120 $6,143 60.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 35 35 $25,900 $6,092 23.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 47 47 $11,750 $5,536 47.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 47 $7,520 $4,388 58.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 45 51 $3,570 $1,942 54.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 11 11 $3,410 $1,721 50.5%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 11 12 $8,880 $1,524 17.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 18 18 $2,880 $1,076 37.4%

About Dr. Adam Berg, MD

Dr. Adam Berg, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629251251.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Berg, MD has received a total of $765.33 in payments from pharmaceutical and medical device companies, with $306.36 received in 2024. These payments were reported across 31 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($721.37).

As a Medicare-enrolled provider, Berg has provided services to 2,202 Medicare beneficiaries, totaling 2,333 services with total Medicare billing of $250,856. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

Products in Payments

  • RINVOQ (Biological) $162.78
  • XELJANZ (Drug) $98.65
  • ZEPOSIA (Drug) $69.12
  • Da Vinci Surgical System (Device) $48.29
  • RESMETIROM (Drug) $48.22
  • SKYRIZI (Biological) $28.01
  • VELSIPITY (Drug) $27.34
  • LINZESS (Drug) $24.19
  • Linzess (Drug) $23.95
  • ENTYVIO (Biological) $22.67
  • DUPIXENT (Biological) $22.37
  • INTERSTIM (Device) $21.00
  • TREMFYA (Drug) $19.68
  • VOWST (Biological) $19.44
  • OMVOH (Drug) $18.17
  • Motegrity (Drug) $17.00
  • ZEPATIER (Drug) $12.24
  • Entyvio (Biological) $11.45
  • FibroScan (Device) $10.50

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Syracuse